Intraocular inflammation as a major adverse event of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: from clinical trials to real-world practice.
Saved in:
| Title: | Intraocular inflammation as a major adverse event of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: from clinical trials to real-world practice. |
|---|---|
| Authors: | Kim JH; Department of Ophthalmology, Kim's Eye Hospital, Seoul, South Korea. |
| Source: | Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jun; Vol. 23 (6), pp. 659-661. Date of Electronic Publication: 2024 May 06. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
